Health Master
Junior member
- Messages
- 19
- Likes
- 2
Allergic Rhinitis Market with the cumulative impact of COVID-19 expected to reach 5 BB.
https://www.globenewswire.com/news-release/2021/01/19/2160474/0/en/Allergic-Rhinitis-Drugs-Market-Research-Report-by-Route-of-Administration-by-Class-of-Drugs-by-Application-Global-Forecast-to-2025-Cumulative-Impact-of-COVID-19.html
Auris Medical Holding Ltd. (EARS), capturing 5% of the market would realize $250MM in revenues/ 11MM Shares outstanding = $22 per share in Revenue, at comparable 5X Sales= $110 per share stock.
https://www.globenewswire.com/news-release/2021/01/19/2160474/0/en/Allergic-Rhinitis-Drugs-Market-Research-Report-by-Route-of-Administration-by-Class-of-Drugs-by-Application-Global-Forecast-to-2025-Cumulative-Impact-of-COVID-19.html
Auris Medical Holding Ltd. (EARS), capturing 5% of the market would realize $250MM in revenues/ 11MM Shares outstanding = $22 per share in Revenue, at comparable 5X Sales= $110 per share stock.
